Literature DB >> 3762018

Additive positive inotropic effects of milrinone, ouabain and calcium in diseased human ventricular myocardium.

L Brown, M Näbauer, E Erdmann.   

Abstract

The interactions of milrinone, ouabain and calcium on force of contraction in isolated, contracting human papillary muscle strips were measured. Milrinone (EC50, 8 X 10(-5)M) increased force of contraction maximally by 2.8 +/- 0.8 mN at 5 X 10(-4)M; significantly less than either ouabain (1 X 10(-7)M; 4.8 +/- 0.5 mN increase) or calcium (15 mM; 6.2 +/- 0.6 mN increase). A submaximal, but not a maximal, inotropic effect of ouabain could be increased by the addition of milrinone; in contrast, both ouabain and calcium increased the maximal inotropic effect of milrinone by 1.7 +/- 0.2 mN and 2.7 +/- 0.3 mN, respectively. The combined inotropic effect of milrinone with either ouabain of 4.2 +/- 0.3 mN or calcium of 5.6 +/- 0.4 mN was not different from that with calcium or ouabain alone. We conclude that further positive inotropic effects should be expected when digitalis is given to patients with congestive heart failure who are already optimally treated with milrinone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762018     DOI: 10.1007/bf01712056

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  21 in total

1.  Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of beta-adrenergic receptor, adenylate cyclase, and ventricular contraction.

Authors:  J Tse; J R Powell; C A Baste; R E Priest; J F Kuo
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

2.  Impaired cardiac contractile response to isoproterenol in the spontaneously hypertensive rat.

Authors:  M Saragoca; R C Tarazi
Journal:  Hypertension       Date:  1981 May-Jun       Impact factor: 10.190

3.  Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.

Authors:  B E Jaski; M A Fifer; R F Wright; E Braunwald; W S Colucci
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics.

Authors:  R Bendersky; K Chatterjee; W W Parmley; B H Brundage; T A Ports
Journal:  Am J Cardiol       Date:  1981-09       Impact factor: 2.778

5.  Reversible inhibition of adenylate cyclase activity in the ischemic myocardium.

Authors:  L Will-Shahab; E G Krause; S Bartel; W Schulze; I Küttner
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

6.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

7.  Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.

Authors:  D S Baim; A V McDowell; J Cherniles; E S Monrad; J A Parker; J Edelson; E Braunwald; W Grossman
Journal:  N Engl J Med       Date:  1983-09-29       Impact factor: 91.245

8.  Inotropic and vasodilator effects of amrinone on isolated human tissue.

Authors:  P T Wilmshurst; J M Walker; C H Fry; J P Mounsey; C H Twort; B T Williams; M J Davies; M M Webb-Peploe
Journal:  Cardiovasc Res       Date:  1984-05       Impact factor: 10.787

9.  Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol.

Authors:  R Ginsburg; M R Bristow; M E Billingham; E B Stinson; J S Schroeder; D C Harrison
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

10.  Responses to amrinone in isolated cardiac muscles from cat, rabbit, and guinea pig.

Authors:  P K Siegl; G Morgan; C S Sweet
Journal:  J Cardiovasc Pharmacol       Date:  1984 Mar-Apr       Impact factor: 3.105

View more
  1 in total

Review 1.  The effectiveness of inotropic agents in isolated cardiac preparations from the human heart.

Authors:  E Erdmann
Journal:  Klin Wochenschr       Date:  1988-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.